Injection sclerotherapy for spider telangiectasias: a 20-year experience with sodium tetradecyl sulfate.
A 20-year experience using sodium tetradecyl sulfate (Sotradecol, Elkins-Sinn, Inc., Cherry Hill, NJ) for the injection treatment of spider telangiectasias is reviewed. Of 1426 legs injected, 882 were treated with a 1%-solution injected directly into the spider veins, and 264 were injected directly with a 1/3%-solution. With the 1/3%-solution, the remaining 280 legs had the blue veins feeding the spider telangiectasias injected rather than the spider itself. When injected directly into the spider veins, the lesser concentration gave fewer ulcerations and less pigmentation, but equal treatment results. Injecting the subcutaneous feeder veins appears to provide more permanent clearing of the lesions with fewer recurrences and no side effects. No allergic or other major complications occurred with the injection treatments.
Tretbar
L L
LL
University of Missouri, Kansas City, School of Medicine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005233:Fatty Alcohols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced / Q000628:therapy; D012008:Recurrence; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D012981:Sodium Tetradecyl Sulfate / Q000009:adverse effects / Q000627:therapeutic use*; D013684:Telangiectasis / Q000628:therapy*
D005233:Fatty Alcohols; D012597:Sclerosing Solutions; D012981:Sodium Tetradecyl Sulfate